{"id":"traditional-antiplatelet-therapy-control-group","safety":{"commonSideEffects":[{"rate":"1-5","effect":"Bleeding"},{"rate":"1-3","effect":"Gastrointestinal bleeding"},{"rate":"5-15","effect":"Dyspepsia"},{"rate":"0.5-1","effect":"Intracranial hemorrhage"}]},"_chembl":{"chemblId":"CHEMBL2108795","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This control group represents standard-of-care antiplatelet agents (typically aspirin and/or clopidogrel) that work by irreversibly or reversibly inhibiting platelet activation and aggregation. These agents reduce the formation of pathological blood clots in cardiovascular and cerebrovascular disease by blocking platelet-to-platelet interactions and adhesion to vessel walls.","oneSentence":"Traditional antiplatelet therapy inhibits platelet aggregation through multiple pathways to reduce thrombotic events.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:13:23.342Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Secondary prevention of myocardial infarction"},{"name":"Stroke prevention"},{"name":"Peripheral arterial disease"}]},"trialDetails":[{"nctId":"NCT07329751","phase":"NA","title":"Based on the Spatio-temporal Coding Characteristics of Frontotemporal Network, This Paper Explores the Mechanism of Five-tone Speech Training in Reshaping Language Fluency Function.","status":"NOT_YET_RECRUITING","sponsor":"Fujian University of Traditional Chinese Medicine","startDate":"2025-12-31","conditions":"Aphasia","enrollment":120},{"nctId":"NCT07286110","phase":"PHASE1","title":"Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-12-30","conditions":"Moyamoya Disease, Moyamoya Syndrome","enrollment":66},{"nctId":"NCT06269432","phase":"PHASE4","title":"Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE（PATH-STROKE）","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2023-01-01","conditions":"Ischemic Stroke, Antiplatelet Drug","enrollment":1020},{"nctId":"NCT01677208","phase":"PHASE4","title":"Danhong Injection in the Treatment of Acute Ischemic Stroke","status":"COMPLETED","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2013-03-13","conditions":"Acute Stroke","enrollment":1503},{"nctId":"NCT05266326","phase":"NA","title":"Bloodletting Puncture in the Treatment of Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Chongqing Traditional Chinese Medicine Hospital","startDate":"2022-03-08","conditions":"Acute Ischemic Stroke","enrollment":360},{"nctId":"NCT02176395","phase":"PHASE4","title":"Multi-\"Omics\" Research of Danhong Injection to Treat Acute Ischemic Stroke","status":"COMPLETED","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2014-06","conditions":"Acute Stroke","enrollment":46},{"nctId":"NCT02918045","phase":"NA","title":"Dental Extractions in Patients Under Dual Antiplatelet Therapy","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2017-04-11","conditions":"Blood Coagulation Disorders","enrollment":60},{"nctId":"NCT02618265","phase":"NA","title":"Mobile Terminal Based Management of Stroke Secondary Prevention Adminstration Effect Research","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2016-01","conditions":"Stroke","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Traditional Antiplatelet Therapy Control Group","genericName":"Traditional Antiplatelet Therapy Control Group","companyName":"Sichuan Provincial People's Hospital","companyId":"sichuan-provincial-people-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Traditional antiplatelet therapy inhibits platelet aggregation through multiple pathways to reduce thrombotic events. Used for Acute coronary syndrome, Secondary prevention of myocardial infarction, Stroke prevention.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}